Six female patients with medullary thyroid carcinoma were treated with doxorubicin (50 mg/m2) and cis-diammine dichloroplatinum (70 mg/m2) every three weeks. No patients responded to therapy as was suggested by serial serum calcitonin concentrations before and after treatment.